| Protein carbonylation and lipid peroxidation in hematological malignancies A Rodríguez-García, R García-Vicente, ML Morales, A Ortiz-Ruiz, ... Antioxidants 9 (12), 1212, 2020 | 41 | 2020 |
| MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia ML Morales, A Arenas, A Ortiz-Ruiz, A Leivas, I Rapado, ... Scientific reports 9 (1), 18630, 2019 | 32 | 2019 |
| Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse E Onecha, I Rapado, ML Morales, G Carreño-Tarragona, ... Haematologica 106 (9), 2325, 2021 | 25 | 2021 |
| CNL and aCML should be considered as a single entity based on molecular profiles and outcomes G Carreño-Tarragona, A Álvarez-Larrán, C Harrison, JC Martínez-Ávila, ... Blood Advances 7 (9), 1672-1681, 2023 | 13 | 2023 |
| Myc-related mitochondrial activity as a novel target for multiple myeloma A Ortiz-Ruiz, Y Ruiz-Heredia, ML Morales, P Aguilar-Garrido, ... Cancers 13 (7), 1662, 2021 | 13 | 2021 |
| Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma A Rodríguez-García, M Linares, ML Morales, S Allain-Maillet, ... Frontiers in Immunology 12, 797209, 2022 | 11 | 2022 |
| Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms AA Cortés, RA Diaz, P Hernández-Campo, J Gorrochategui, D Primo, ... haematologica 104 (5), 937, 2019 | 10 | 2019 |
| Service-learning, movies, and infectious diseases: implementation of an active educational program in microbiology as a tool for engagement in social justice M Linares, N López-Ejeda, P Álvarez, E Culebras, E Díaz, MT García, ... Frontiers in Microbiology 12, 589401, 2021 | 7 | 2021 |
| Long-term human hematopoietic stem cell culture in microdroplets P Carreras, I González, M Gallardo, A Ortiz-Ruiz, ML Morales, J Encinas, ... Micromachines 12 (1), 90, 2021 | 7 | 2021 |
| Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma A Rodríguez-García, A Arroyo, R García-Vicente, ML Morales, ... Clinical Cancer Research 30 (4), 904-917, 2024 | 6 | 2024 |
| High-throughput CRISPR screening in hematological neoplasms R Ancos-Pintado, I Bragado-García, ML Morales, R García-Vicente, ... Cancers 14 (15), 3612, 2022 | 6 | 2022 |
| NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy L Hurtado-Navarro, EJ Cuenca-Zamora, L Zamora, B Bellosillo, E Such, ... Cell Reports Medicine 4 (12), 2023 | 4 | 2023 |
| Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy A Rodríguez-García, ML Morales, V Garrido-García, I García-Baquero, ... Antioxidants 8 (11), 508, 2019 | 4 | 2019 |
| Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses A Rodríguez-García, N Mennesson, G Hernandez-Ibarburu, ML Morales, ... Haematologica 109 (1), 272, 2024 | 2 | 2024 |
| Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? ML Morales, F Ferrer-Marín Cancers 15 (4), 1348, 2023 | 2 | 2023 |
| Digital system augmented by artificial intelligence to interpret bone marrow samples for hematological disease diagnosis D Bermejo-Peláez, SR Charro, MG Roa, R Trelles-Martínez, ... medRxiv, 2022.08. 30.22279373, 2022 | 1 | 2022 |
| Microfluidic-assisted engineering of multi-layered microcapsules for 3D stem cell culture PC Romeo, I Gonzalez, A Ortiz, ML Morales, T Cedena, J Martinez-Lopez Microfluidics, BioMEMS, and Medical Microsystems XVIII 11235, 123-131, 2020 | 1 | 2020 |
| Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity A Ortiz-Ruiz, Y Ruiz-Heredia, M Samur, P Aguilar-Garrido, ML Morales, ... Blood 134, 4408, 2019 | 1 | 2019 |
| Preclinical evidence that trametinib enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia J Martinez-Lopez, M Linares, ML Morales, A Arenas, I Zagorac, RM Ayala, ... Blood, The Journal of the American Society of Hematology 128 (22), 1581-1581, 2016 | 1 | 2016 |
| miR‐146a−/− mice model reveals that NF‐κB inhibition reverts inflammation‐driven myelofibrosis‐like phenotype EJ Cuenca‐Zamora, PJ Guijarro‐Carrillo, MJ López‐Poveda, ML Morales, ... American Journal of Hematology 99 (7), 1326-1337, 2024 | | 2024 |
joaquin martinez lopezComplutense University在 ucm.es 的电子邮件经过验证
